[{"address1": "Tower B, Avenue 3", "address2": "Unit 02, Level 10 The Vertical Business Suite II Bangsar South 8 Jalan Kerinchi", "city": "Kuala Lumpur", "zip": "59200", "country": "Malaysia", "phone": "60 1 307 241 6898", "website": "https://www.bionexusgenelab.com", "industry": "Specialty Chemicals", "industryKey": "specialty-chemicals", "industryDisp": "Specialty Chemicals", "sector": "Basic Materials", "sectorKey": "basic-materials", "sectorDisp": "Basic Materials", "longBusinessSummary": "BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers. Its products are used to produce handrails, bench tops, automotive and aero parts, and paneling for hospital, laboratory, industrial clean rooms, and covers for various instruments used in manufacturing. The company also involves in developing and providing non-invasive liquid biopsy tests for the early detection of biomarkers to detect potential risk of diseases. It markets its products through its website, warehouse, marketing personnel, and suppliers. The company was incorporated in 2017 and is based in Kuala Lumpur, Malaysia.", "fullTimeEmployees": 30, "companyOfficers": [{"maxAge": 1, "name": "Mr. Su-Leng  Tan", "age": 39, "title": "CEO, Acting CFO, Secretary & Director", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 16000, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Kwan Wah Chan", "title": "Marketing Manager", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Too Kam  Tham", "title": "Managing Director", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "maxAge": 86400, "priceHint": 4, "previousClose": 0.4504, "open": 0.45, "dayLow": 0.4335, "dayHigh": 0.4789, "regularMarketPreviousClose": 0.4504, "regularMarketOpen": 0.45, "regularMarketDayLow": 0.4335, "regularMarketDayHigh": 0.4789, "beta": 1.848, "volume": 31968, "regularMarketVolume": 31968, "averageVolume": 184585, "averageVolume10days": 193240, "averageDailyVolume10Day": 193240, "bid": 0.3291, "ask": 0.5855, "bidSize": 200, "askSize": 200, "marketCap": 8234597, "fiftyTwoWeekLow": 0.31, "fiftyTwoWeekHigh": 3.39, "priceToSalesTrailing12Months": 0.89670545, "fiftyDayAverage": 0.4678, "twoHundredDayAverage": 0.57661, "currency": "USD", "enterpriseValue": 3271997, "profitMargins": -0.24014999, "floatShares": 10260793, "sharesOutstanding": 17967700, "sharesShort": 103130, "sharesShortPriorMonth": 224802, "sharesShortPreviousMonthDate": 1721001600, "dateShortInterest": 1723680000, "sharesPercentSharesOut": 0.0057, "heldPercentInsiders": 0.633, "heldPercentInstitutions": 0.00366, "shortRatio": 0.9, "shortPercentOfFloat": 0.0058999998, "impliedSharesOutstanding": 17967700, "bookValue": 0.54, "priceToBook": 0.8487037, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1719705600, "netIncomeToCommon": -2205379, "trailingEps": -0.15, "enterpriseToRevenue": 0.356, "enterpriseToEbitda": -2.245, "52WeekChange": -0.7368421, "SandP52WeekChange": 0.24059486, "exchange": "NCM", "quoteType": "EQUITY", "symbol": "BGLC", "underlyingSymbol": "BGLC", "shortName": "BioNexus Gene Lab Corp", "longName": "BioNexus Gene Lab Corp.", "firstTradeDateEpochUtc": 1610116200, "timeZoneFullName": "America/New_York", "timeZoneShortName": "EDT", "uuid": "41fa38c7-39a9-3634-832e-8b50e40e0c35", "messageBoardId": "finmb_600164494", "gmtOffSetMilliseconds": -14400000, "currentPrice": 0.4583, "recommendationKey": "none", "totalCash": 5414033, "totalCashPerShare": 0.301, "ebitda": -1457244, "totalDebt": 451450, "quickRatio": 4.866, "currentRatio": 5.605, "totalRevenue": 9183168, "debtToEquity": 4.729, "revenuePerShare": 0.526, "returnOnAssets": -0.10106, "returnOnEquity": -0.28439, "freeCashflow": -190546, "operatingCashflow": -1866236, "revenueGrowth": -0.231, "grossMargins": 0.1388, "ebitdaMargins": -0.15869, "operatingMargins": 0.13125, "financialCurrency": "USD", "trailingPegRatio": null, "__fetch_time": "2024-08-29"}]